Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KVISTGAARD, Denmark - February 8, 2013 - Bavarian...
-
Amicus Therapeutics Announces Posters and Presentations at Lysosomal Disease Network WORLD Symposium
CRANBURY, N.J., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD) today announced that 2 oral presentations and 5 posters related to its investigational pharmacological chaperones...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 7, 2013) - East West Petroleum Corp. (TSX VENTURE:EW) (the "Company" or "East West") is pleased to provide details on its 2013 capital...
-
SAN DIEGO, Feb. 7, 2013 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc., a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators, today announced that Christian...
-
NEW YORK, Feb. 7, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), an emerging leader in the fast growing cell therapy market, today announced that the Company and...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 7, 2013) - Gold Standard Ventures Corp. (TSX VENTURE:GSV)(NYSE MKT:GSV)(NYSE Amex:GSV) ("Gold Standard" or the "Company")...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 7, 2013) - All dollar amounts expressed in this news release are in Canadian dollars unless otherwise noted. Teck Resources Limited...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} 2013 Value Drivers: · Initiate Phase 2...
-
SOUTH SAN FRANCISCO, Calif., Feb. 6, 2013 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced today...
-
HASBROUCK HEIGHTS, N.J., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) announced today that CEO Paul Averback will be presenting at the 15th Annual BIO CEO &...